News | August 06, 2021
Strides to acquire US manufacturing facility of Endo for $24 mn
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
He will be stationed at the company HQ in Bengaluru, India
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Deal for 100 million doses with additional 100 million through 2023
It had an estimated market size of US $ 32 million as of June 2021
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
AstraZeneca, Sinopharm and Moderna were part of the study
Ibuprofen and Famotidine tablets approved by FDA
Subscribe To Our Newsletter & Stay Updated
